Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-140290
Filing Date
2015-04-21
Accepted
2015-04-21 17:11:09
Documents
4
Period of Report
2015-05-27
Effectiveness Date
2015-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d900128ddef14a.htm DEF 14A 979902
2 GRAPHIC g900128g49h99.jpg GRAPHIC 86894
3 GRAPHIC g900128pc_pg01.jpg GRAPHIC 68912
4 GRAPHIC g900128pc_pg02.jpg GRAPHIC 76013
  Complete submission text file 0001193125-15-140290.txt   1300803
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 15783822
SIC: 2834 Pharmaceutical Preparations